ArticleThe Lancet regional health. Europe2026
Trends in sudden death-attributed mortality across Europe, 2010-2020: a retrospective population-based analysis.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sudden death remains a major global cause of mortality, yet recent European trends are poorly characterized. We analyzed sudden death mortality across Europe from 2010 to 2020, assessing variations by age, sex, and region. Methods: We extracted sudden death-attributable mortality data from the World Health Organization (WHO) mortality dataset for 2010-2020. Age-adjusted mortality rates (AAMRs) were analyzed using joinpoint regression modeling, expressed as average annual percent change (AAPC) with 95% confidence intervals (CIs). A parallelism test compared trend differences across groups. Findings: From 2010 to 2020, there were 2,583,559 attributed sudden death (1,935,741 men and 647,818 women) in 26 European countries. Overall, the AAMR increased [AAPC: +2.9% (95% CI: 2.0-4.1), p < 0.001], with a significantly greater increase in women compared to men (p = 0.01). Regionally, AAMRs decreased in Western Europe [AAPC: -2.0% (95% CI: -2.1 to -0.1), p = 0.02], plateaued in Northern Europe [AAPC: -2.0% (95% CI: -4.7 to 0.8), p = 0.15], while increasing in Southern [+3.3% (95% CI: 1.5-8.2, p = 0.001] and Eastern Europe [AAPC: +3.4% (95% CI: 1.7-5.0), p < 0.001]. At the country level, substantial differences were observed, with Austria and Belgium showing the highest reduction of AAPC (-8.0% and -7.9%, respectively), contrasting with an increase in Spain and Germany (+3.3% and +2.8%, respectively). Interpretation: Rising sudden death mortality in Europe likely reflected evolving sex- and region-specific patterns, including the increasing cardiovascular risk burden among women and broader demographic changes across different parts of Europe. Equitable, multidisciplinary strategies are needed to curb this trend. Funding: None.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.